X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (36193) 36193
Book Chapter (96) 96
Government Document (64) 64
Magazine Article (45) 45
Publication (12) 12
Conference Proceeding (10) 10
Newsletter (9) 9
Web Resource (7) 7
Dissertation (6) 6
Streaming Video (4) 4
Book / eBook (3) 3
Book Review (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27743) 27743
oncology (17778) 17778
phase-iii (12294) 12294
female (12277) 12277
phase-iii trial (10546) 10546
chemotherapy (10156) 10156
male (10028) 10028
middle aged (8643) 8643
cancer (8272) 8272
aged (8018) 8018
clinical trials, phase iii as topic (7626) 7626
treatment outcome (7511) 7511
adult (6644) 6644
antineoplastic combined chemotherapy protocols - therapeutic use (5345) 5345
care and treatment (4821) 4821
double-blind (4797) 4797
randomized controlled trials as topic (4686) 4686
survival (4253) 4253
antineoplastic agents - therapeutic use (4048) 4048
pharmacology & pharmacy (3931) 3931
prognosis (3756) 3756
radiotherapy (3528) 3528
therapy (3489) 3489
aged, 80 and over (3418) 3418
clinical trials (3394) 3394
neoplasm staging (3218) 3218
surgery (3218) 3218
randomized phase-iii (3164) 3164
cisplatin (3133) 3133
research (3040) 3040
analysis (3031) 3031
retrospective studies (2943) 2943
disease-free survival (2926) 2926
lung neoplasms - drug therapy (2864) 2864
animals (2845) 2845
trial (2839) 2839
metastasis (2699) 2699
open-label (2689) 2689
medicine & public health (2684) 2684
randomized-trial (2668) 2668
hematology, oncology and palliative medicine (2568) 2568
drug therapy (2499) 2499
survival analysis (2415) 2415
carcinoma, non-small-cell lung - drug therapy (2383) 2383
health aspects (2363) 2363
carcinoma (2346) 2346
efficacy (2293) 2293
1st-line treatment (2264) 2264
combined modality therapy (2228) 2228
clinical trials, phase ii as topic (2155) 2155
survival rate (2133) 2133
patients (2130) 2130
bevacizumab (2105) 2105
risk factors (1975) 1975
radiation-therapy (1895) 1895
paclitaxel (1869) 1869
cancer therapies (1841) 1841
tumors (1822) 1822
lung cancer (1808) 1808
hematology (1804) 1804
safety (1801) 1801
lung neoplasms - pathology (1785) 1785
docetaxel (1784) 1784
quality of life (1779) 1779
clinical trials as topic (1733) 1733
quality-of-life (1731) 1731
combination (1681) 1681
gemcitabine (1675) 1675
cell lung-cancer (1670) 1670
antineoplastic combined chemotherapy protocols - adverse effects (1660) 1660
medicine, general & internal (1660) 1660
breast cancer (1654) 1654
fluorouracil (1643) 1643
chemotherapy, adjuvant (1641) 1641
breast neoplasms - drug therapy (1639) 1639
time factors (1584) 1584
multicenter (1556) 1556
follow-up studies (1531) 1531
neoplasm metastasis (1511) 1511
respiratory system (1511) 1511
immunotherapy (1501) 1501
colorectal cancer (1498) 1498
adjuvant chemotherapy (1488) 1488
carboplatin (1473) 1473
mutation (1453) 1453
adenocarcinoma (1442) 1442
review (1421) 1421
radiology, nuclear medicine & medical imaging (1386) 1386
antineoplastic agents - adverse effects (1373) 1373
young adult (1365) 1365
patient outcomes (1362) 1362
antibodies, monoclonal - therapeutic use (1347) 1347
medicine, research & experimental (1346) 1346
carcinoma, non-small-cell lung - pathology (1336) 1336
medical research (1332) 1332
abridged index medicus (1322) 1322
drug administration schedule (1294) 1294
disease progression (1281) 1281
studies (1281) 1281
deoxycytidine - analogs & derivatives (1277) 1277
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (34867) 34867
German (713) 713
French (696) 696
Japanese (262) 262
Spanish (154) 154
Italian (64) 64
Portuguese (40) 40
Chinese (34) 34
Polish (26) 26
Hungarian (19) 19
Russian (12) 12
Korean (10) 10
Norwegian (9) 9
Czech (8) 8
Turkish (6) 6
Dutch (5) 5
Swedish (5) 5
Finnish (4) 4
Lithuanian (3) 3
Serbian (3) 3
Danish (2) 2
Romanian (2) 2
Hebrew (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2014, Volume 121, Issue 7, pp. 1414 - 1420.e1
Purpose To evaluate the efficacy and safety of intravitreal aflibercept injection (IAI) for the treatment of macular edema secondary to central retinal vein... 
Ophthalmology | TRIAL | BEVACIZUMAB | PHASE-III | SECONDARY | OPHTHALMOLOGY | VEGF TRAP-EYE | RANIBIZUMAB | Dropsy | Edema | Retinal diseases | Consulting services
Journal Article
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 1, pp. 83 - 98.e4
Background Secukinumab, a fully human anti–interleukin-17A monoclonal antibody, has demonstrated efficacy and safety in patients with moderate to severe plaque... 
Dermatology | pooled analysis | phase II studies | phase III studies | psoriasis | secukinumab | long-term safety | Phase III studies | Secukinumab | Long-term safety | Pooled analysis | Psoriasis | Phase II studies | CONTROLLED-TRIAL | CONFIDENCE-INTERVALS | FOLLOW-UP | RISK | long | DERMATOLOGY | LONGITUDINAL ASSESSMENT | CANDIDA-ALBICANS | REGISTRY PSOLAR | DISEASE | DOUBLE-BLIND | HOST-DEFENSE | term safety | Severity of Illness Index | Etanercept - adverse effects | Psoriasis - drug therapy | Etanercept - administration & dosage | Mental Disorders - chemically induced | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Infection - chemically induced | Randomized Controlled Trials as Topic | Clinical Trials, Phase III as Topic | Neoplasms - chemically induced | Interleukin-17 - antagonists & inhibitors | Time Factors | Antibodies, Monoclonal - administration & dosage | Adult | Female | Immunosuppressive Agents - adverse effects | Inflammatory Bowel Diseases - chemically induced | Cardiovascular Diseases - chemically induced | Neutropenia - chemically induced | Immunosuppressive Agents - administration & dosage | Clinical Trials, Phase II as Topic | Medical research | Care and treatment | Interleukins | Clinical trials | Monoclonal antibodies | Medicine, Experimental | Pharmaceutical industry | Consulting services
Journal Article
Journal Article